The consistency of the treatment benefit of remote hemodynamic monitoring in chronic heart failure: a predefined subgroup analysis of the randomised clinical Trial MONITOR-HF.

11 May 2024 (09:06 - 09:14)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Jasper Brugts

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

9 More presentations in this session

Presentation thumbnail

Timing of Cardio-Kidney Protection with SGLT2 Inhibitors: Insights from Four Large-scale Placebo-Controlled Outcome Trials

Doctor M. Vaduganathan (Boston, US)

Presentation thumbnail

Discussant review - CANVAS Program, CREDENCE, DAPA-HF, and DELIVER

Professor M. Packer (Dallas, US)

Presentation thumbnail

Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study

Professor S. Lakhal-Littleton (Oxford, GB)

Presentation thumbnail

Discussant review - IV iron and the heart

Professor E. Jankowska (Wroclaw, PL)

Presentation thumbnail

Impact of a remote monitoring program on all-cause mortality of patients with heart failure: National, real-world evidence of the TELESAT study

Professor N. Girerd (Nancy, FR)

Access the full session

Session thumbnail

Late breaking clinical trials I

The Event

Event poster

Heart Failure 2024

11 May 2024 09:06 CET

You may be interested in

Congress Presentation

Pulmonary artery pressure monitoring: where are we now?

Congress Presentation

Interpreting subgroup analyses: principles and pitfalls

Congress Presentation

Invasive pulmonary artery monitoring

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources